Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.
Sponsor: Beneficência Portuguesa de São Paulo
Summary
To evaluate the use of a pharmacogenetic and pharmacoepigenetic panel for predicting chemotherapy- and immunotherapy-induced cardiotoxicity in cancer patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2026-05-11
Completion Date
2029-12-30
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Locations (6)
Instituto do Câncer do Ceará
Fortaleza, Ceará, Brazil
Complexo Hospitar HUOC/PROCAPE
Recife, Pernambuco, Brazil
Universidade Federal de Santa Catarina
Florianópolis, Santa Catarina, Brazil
Hospital Beneficente UNIMAR
Marília, São Paulo, Brazil
FAMERP - Faculdade de Medicina de São José do Rio Preto
São José do Rio Preto, São Paulo, Brazil
Hospital BP - A Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil